J.P. Morgan Maintains Edwards Lifesciences(EW.US) With Buy Rating

J.P. Morgan analyst Robbie Marcus maintains $Edwards Lifesciences(EW.US)$ with a buy rating.According to TipRanks data, the analyst has a success rate of 54.6% and a total average return of 11.6% over

Futu News18:31 · Ratings

CNBC Halftime Report Final Trades: Edwards Lifesciences, American Tower, Transdigm

CNBC Halftime Report Final Trades: Edwards Lifesciences, American Tower, Transdigm

Benzinga01:00

The Best of Breed Global Stocks for 3Q2024 - BofA

BofA Securities analysts listed the best of breed global stocks for the third quarter of the year.

Seeking AlphaJun 25 21:39

Unusual Options Activity: DDOG, BABA and Others Attract Market Bets, DDOG V/OI Ratio Reaches 162.5

EST Jun 21st Closing Delivery - In the last three hours of trading, 10 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options trend

Futu NewsJun 22 04:30

Peering Into Edwards Lifesciences's Recent Short Interest

Edwards Lifesciences's (NYSE:EW) short percent of float has risen 3.73% since its last report. The company recently reported that it has 8.29 million shares sold short, which is 1.39% of all regular s

BenzingaJun 21 23:00

BofA Securities Maintains Edwards Lifesciences(EW.US) With Buy Rating, Maintains Target Price $105

BofA Securities analyst Travis Steed maintains $Edwards Lifesciences(EW.US)$ with a buy rating, and maintains the target price at $105.According to TipRanks data, the analyst has a success rate of 61.

Futu NewsJun 21 18:31 · Ratings